Over the past decade, a large body of evidence has accumulated supporting the integration
of palliative care into oncology practice for patients with advanced cancer. The question is …

Background Serious illness is often characterised by physical/psychological problems,
family support needs, and high healthcare resource use. Hospital‐based specialist palliative …

Background Family caregivers of patients with advanced cancer often have poor quality of
life (QOL) and mental health. We examined the effectiveness of interventions offering …

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy that continues to
be challenging to treat. PDAC has the lowest 5‐year relative survival rate compared with all …

Background: Pancreatic cancer can be a very debilitating disease. In the USA and around
the world, pancreatic cancer is among the causes of cancer-related deaths. This study aims …

Purpose Pancreatic cancer is a lethal disease. Many patients experience a heavy burden of
cancer-associated symptoms and poor quality of life (QOL). Early palliative care alongside …

The prognosis of pancreatic ductal adenocarcinoma is still the worst among solid tumors. In
this review, a panel of experts addressed the main unanswered questions about the clinical …

ASCO Guidelines provide recommendations with comprehensive review and analyses of
the relevant literature for each recommendation, following the guideline development …

Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related
death in women (7%) and the sixth in men (5%) in Italy, with a life expectancy of around 5 …

Background Most deaths still take place in hospital; cost-effective commissioning of end-of-
life resources is a priority. This review provides clarity on the effectiveness of hospital-based …